EUVIMEDEUVIMED entdecken
Crossref

Intraglandular botulinum toxin in postoperative head and neck fistula: a retrospective analysis

Karthika Chettuvatti, Smriti Panda, Rachit Sood, Abhilash Konkimalla, Alok Thakar, Sandipta Mitra, Amit Kumar, Akshara Palreddy, Sanjay Kumar Meena, Chirom Amit Singh, Kapil Sikka, Rajeev Kumar und 1 weitere

European Archives of Oto-Rhino-Laryngology · 2025

DOI: 10.1007/s00405-024-09189-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Karthika Chettuvatti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head- Neck Surgery, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Postoperative Complications, Cutaneous Fistula, Pharyngeal Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Orocervical (OCF) or pharyngocutaneous fistula (PCF) are one of the disastrous complications of head and neck cancer surgery. Conventional standards of management are predominantly conservative. Though a majority of such patients respond to conservative management, it nevertheless causes significant delay in wound healing. This study explores the role of intraglandular Botulinum toxin injection in shortening the time to fistula healing. METHODS: Retrospective case-control study at a tertiary care oncology center in South Asia from January 2021 to December 2023 on all consecutive patients of OCF/PCF. Patients with any history of head and neck radiation were excluded. The case group received intraglandular (parotid+/-submandibular gland) botulinum toxin injection and conservative management and the control group received only conservative management. The time taken for the fistula to heal was the primary outcome. RESULTS: 31 patients in case and 104 patients were in control group. The mean time from fistula diagnosis till injection was 5.8 ± 3.1 days and the mean fistula healing time in case group was 18.5 ± 7.15 days (Range:10-34 days). The mean total dose of botulinum toxin was 59.2 ± 22.4 MU (Range: 40 to 100 MU). For control group, the mean time taken for the fistula to heal was 26 ± 15 days (Range:15 to 75 days). The difference was statistically significant (p-0.008, 95% CI: -9.0 to -2.0). Adverse effects attributable to botulinum toxin injection were: pain at the injection site (n = 3) and xerostomia (n = 1). On multivariate analysis, intervention with intraglandular botulinum toxin emerged as an independent variable impacting the time taken for fistula closure. CONCLUSION: This is the largest study to show the efficacy of intraglandular botulinum toxin injection in reducing the time taken for healing of postoperative salivary fistula with a tolerable adverse effect profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsPostoperative ComplicationsCutaneous FistulaPharyngeal DiseasesBotulinum Toxins, Type AOral FistulaBotulinum ToxinsHumansRetrospective StudiesMaleFemaleMiddle AgedCase-Control StudiesAgedAdultSubmandibular GlandWound HealingParotid Gland

Stichwörter der Autor:innen

Botulinum ToxinFistulaHead and neck cancerParotidSalivary gland

Substanzen

Botulinum Toxins, Type ABotulinum Toxins

Autor:innen und Institutionen

  • Department of Otorhinolaryngology and Head- Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Otorhinolaryngology and Head- Neck Surgery, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India. smriti.panda.87@gmail.com.
  • Department of Surgical Oncology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India.
  • Department of Radiology, All India Institute of Medical Sciences, New Delhi, India.

Zitieren

APA

Chettuvatti, K., Panda, S., Sood, R., Konkimalla, A., Thakar, A., Mitra, S., Kumar, A., Palreddy, A., Meena, S. K., Singh, C. A., Sikka, K., Kumar, R., & Singh, A. (2025). Intraglandular botulinum toxin in postoperative head and neck fistula: a retrospective analysis. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-09189-5

Vancouver

Chettuvatti K, Panda S, Sood R, Konkimalla A, Thakar A, Mitra S, et al. Intraglandular botulinum toxin in postoperative head and neck fistula: a retrospective analysis. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-024-09189-5

BibTeX
@article{Chettuvatti2025,
  author = {Chettuvatti, Karthika and Panda, Smriti and Sood, Rachit and Konkimalla, Abhilash and Thakar, Alok and Mitra, Sandipta and Kumar, Amit and Palreddy, Akshara and Meena, Sanjay Kumar and Singh, Chirom Amit and Sikka, Kapil and Kumar, Rajeev and Singh, Anup},
  title = {Intraglandular botulinum toxin in postoperative head and neck fistula: a retrospective analysis},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2025},
  doi = {10.1007/s00405-024-09189-5}
}
Kostenlos starten →